Personalized Breast Cancer Treatment
61 – 70 of 150
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
- Contribution to journal › Article
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
- Contribution to journal › Article
-
Mark
Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
- Contribution to journal › Article
-
Mark
No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery : 20-Year Follow-up of the Randomized SweBCGRT Trial
- Contribution to journal › Article
-
Mark
Evolution of estrogen receptor status from primary tumors to metastasis and serially collected circulating tumor cells
- Contribution to journal › Article
-
Mark
Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
- Contribution to journal › Article
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
- Contribution to journal › Article
-
Mark
Psychological resilience and health-related quality of life in Swedish women with newly diagnosed breast cancer
- Contribution to journal › Article
-
Mark
Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
- Contribution to journal › Article
-
Mark
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP)
- Contribution to journal › Article
